Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes

[1]  Salam A. Assi,et al.  UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO , 2016, Leukemia.

[2]  S. Raimondi,et al.  Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. , 2015, Blood.

[3]  D. Reinhardt,et al.  Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial , 2015, Annals of Hematology.

[4]  Cheng Cheng,et al.  The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.

[5]  S. Emmrich,et al.  LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia , 2014, Molecular Cancer.

[6]  S. Miyano,et al.  The landscape of somatic mutations in Down syndrome–related myeloid disorders , 2013, Nature Genetics.

[7]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[8]  R. Pieters,et al.  NUP98/JARID1A Is a New Recurrent Genetic Abnormality in Pediatric Acute Megakaryoblastic Leukemia with a Distinct HOX -Gene Expression Pattern , 2012 .

[9]  Heather L. Mulder,et al.  An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. , 2012, Cancer cell.

[10]  D. Reinhardt,et al.  GATA1-Mutations-assoziierte Leukämien bei Kindern mit Trisomie 21-Mosaik , 2012, Klinische Pädiatrie.

[11]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[12]  J. Crispino,et al.  Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. , 2012, The Journal of clinical investigation.

[13]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[14]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[15]  F. Bessho,et al.  Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy , 2010, International journal of hematology.

[16]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[17]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[18]  J. Downing,et al.  Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia , 2009, Proceedings of the National Academy of Sciences.

[19]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[20]  N. Sebire,et al.  ERG is a megakaryocytic oncogene. , 2009, Cancer research.

[21]  Cheng Cheng,et al.  Reference alignment of SNP microarray signals for copy number analysis of tumors , 2009, Bioinform..

[22]  Joshua M. Korn,et al.  Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.

[23]  Elizabeth A. Kruse,et al.  The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells , 2008, Nature Immunology.

[24]  T. Alonzo,et al.  Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: Report from the Children's Oncology Group , 2007, Pediatric blood & cancer.

[25]  E. Passegué,et al.  Evidence that the Pim1 kinase gene is a direct target of HOXA9. , 2007, Blood.

[26]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[27]  D. Reinhardt,et al.  AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity , 2005, Leukemia.

[28]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[29]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[30]  Cheng Li,et al.  dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..

[31]  M. Derynck,et al.  The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. , 2004, Blood.

[32]  S. Jhanwar,et al.  Chromosome 19 abnormalities are commonly seen in AML, M7. , 2002, Blood.

[33]  M. Vignetti,et al.  Acute megakaryoblastic leukemia: experience of GIMEMA trials , 2002, Leukemia.

[34]  R. Berger,et al.  Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH). , 2002, Blood.

[35]  Dean Nizetic,et al.  Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia , 2001, Nature Genetics.

[36]  F. Behm,et al.  Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. , 2001, Blood.

[37]  Nicole Dastugue,et al.  Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[39]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[40]  A. Baruchel,et al.  Nonrandom t(1;22)(p12-p13;q13) in acute megakaryocytic malignant proliferation. , 1991, Cancer genetics and cytogenetics.

[41]  D. Reinhardt,et al.  [GATA1-mutation associated leukemia in children with trisomy 21 mosaic]. , 2012, Klinische Padiatrie.

[42]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..